Pro-HIFU System - Pro300 - Prostate disease and Benign Prostate Hypertrophy

Non-invasive High-Intensity Focused Ultrasound Therapy

Treatment Solution

The Pro-HIFU Pro300 System is a non-invasive therapeutic platform that utilizes High-Intensity Focused Ultrasound (HIFU) to ablate targeted pathological tissue without surgical incision. By concentrating ultrasound energy at a precise focal point, the system induces thermal coagulative necrosis while preserving surrounding healthy structures.

Pro-HIFU offers an effective, uterus-preserving and organ-preserving treatment option for selected benign and malignant conditions, providing patients with faster recovery, reduced complications, and improved quality of life.

Disease Overview

What is Prostate Disease and Benign Prostate Hypertrophy?

Prostate disease encompasses both benign and malignant conditions, most commonly benign prostatic hyperplasia (BPH) and prostate cancer. BPH refers to a non-cancerous enlargement of the prostate that may lead to urinary symptoms, while prostate cancer arises from abnormal cellular growth within the gland and may require further investigation to define its extent and significance. Detailed clinical and radiological assessment is essential in guiding management decisions, especially in selected cases where a targeted, tissue-focused treatment strategy may be considered.

Clinical Applications

How Pro-HIFU Treats Prostate Disease and Benign Prostate Hypertrophy

For prostate disease, the PRO300 uses focused ultrasound energy to target carefully selected areas within the gland in a controlled and non-invasive manner. By combining robotic positioning with image-guided treatment planning, the system is designed to support precise energy delivery while helping preserve surrounding tissue. This allows for a highly targeted treatment approach in selected cases of benign or malignant prostate disease where accuracy is a key consideration.

Key Benefits